Circular No. 06/2017/TT-BYT dated May 03, 2017 of the Ministry of Health on the List of toxic drugs and toxic medicinal ingredients

  • Summary
  • Content
  • Status
  • Vietnamese
  • Download
Save

Please log in to use this function

Send link to email

Please log in to use this function

Error message
Font size:

ATTRIBUTE

Circular No. 06/2017/TT-BYT dated May 03, 2017 of the Ministry of Health on the List of toxic drugs and toxic medicinal ingredients
Issuing body: Ministry of HealthEffective date:
Known

Please log in to a subscriber account to use this function.

Don’t have an account? Register here

Official number:06/2017/TT-BYTSigner:Truong Quoc Cuong
Type:CircularExpiry date:Updating
Issuing date:03/05/2017Effect status:
Known

Please log in to a subscriber account to use this function.

Don’t have an account? Register here

Fields:Medical - Health

SUMMARY

List of toxic drugs and toxic medicinal ingredients

 

On May 03, 2017, the Ministry of Health issued the Circular No. 06/2017/TT-BYT on the List of toxic drugs and toxic medicinal ingredients.

Accordingly, Drugs and medicinal ingredients that threaten to cause one or several of the following effects on human body shall be selected for inclusion in the List of toxic drugs and toxic medicinal ingredients such as  Carcinogenicity; Teratogenicity or Developmental toxicity; Reproductive toxicity; Organ toxicity at low doses; Genotoxicity. The List includes 111 toxic drugs and toxic medicinal ingredients, within that includes: Abiraterone; Azacitidine; Colistin; Docetaxel; Oxytocin; Paclitaxel; Pazopanib; Topotecan; Triptorelin; Vincristine…

In accordance with the regulations, with regard to drugs and medicinal ingredients that have registration number of import permit before July 01, 2017, holders of certificate of free sales and importers of drugs and medicinal ingredients must classify, update and provide additional information concerning classifications of drugs and medicinal ingredients in accordance with regulations herein on drug labels and package inserts according to the roadmap prescribed in Minister of Health’s Circulars on labeling of drugs and medicinal ingredients before selling such of drugs and medicinal ingredients on the market.

Drugs and active ingredients of which applications for sale registration in Vietnam or applications for permit to import drugs without certificate of free sale in Vietnam have been submitted to the Drug Administration of Vietnam before July 01, 2017 but are not yet processed must be classified in accordance with regulations herein.

This Circular takes effect on July 01, 2017.
For more details, click here.
Download files here.
LuatVietnam.vn is the SOLE distributor of English translations of Official Gazette published by the Vietnam News Agency
Effect status: Known

THE MINISTRY OF HEALTH

Circular No. 06/2017/TT-BYT datedMay 03, 2017 of the Ministry of Health on the Listof toxic drugs and toxic medicinal ingredients

Pursuant to the Pharmaceutical Law dated April 06, 2016;

Pursuant to the Government’s Decree No. 63/2012/ND-CP dated August 31, 2012 defining Functions, Tasks, Powers and Organizational Structure of Ministry of Health;

At the request of Director of the Drug Administration of Vietnam;

Minister of Health promulgates the “Circular on promulgation of List of Toxic Drugs and Toxic Medicinal Ingredients”.

Article 1. Scopeof adjustment

This Circular provides for rules for compiling the List of toxic drugs and toxic medicinal ingredients and criteria for selection of toxic drugs and toxic medicinal ingredients for inclusion in the List; the List of toxic drugs and toxic medicinal ingredients as active ingredients and modern drugs; purposes of the List and implementation thereof.

Article 2. Rules for compiling the List of toxic drugs and toxic medicinal ingredients and criteria for selection of toxic drugs and toxic medicinal ingredients for inclusion in the List

1. Rules for compiling the List of toxic drugs and toxic medicinal ingredients:

a) Ensure safety for drug users;

b) Ensure people’s timely access to drugs;

c) Conform to the reality of use and supply of drugs in Vietnam;

d) Be harmonized with rules and regulations on classification of toxic drugs and toxic medicinal ingredients announced by the States in the region and the world.

dd) Base on the approved package inserts, the National Pharmacopoeia, the world drug databases, articles published on academic journals and other relevant documents.

2. Criteria for selection of toxic drugs and toxic medicinal ingredients for inclusion in the List of toxic drugs and toxic medicinal ingredients:

Drugs and medicinal ingredients that threaten to cause one or several of the following effects on human body shall be selected for inclusion in the List of toxic drugs and toxic medicinal ingredients:

a) Carcinogenicity;

b) Teratogenicity or Developmental toxicity;

c) Reproductive toxicity;

d) Organ toxicity at low doses;

dd) Genotoxicity.

Article 3.  List of toxic drugs and toxic medicinal ingredients

The List of toxic drugs and toxic medicinal ingredients is enclosed with this Circular.

Article 4.  Purposes of List of toxic drugs and toxic medicinal ingredients

The List of toxic drugs and toxic medicinal ingredients is aimed to serve regulatory authorities in course of implementation of regulations on management of toxic drugs and toxic medicinal ingredients in terms of trading, labeling, prescription, distribution, preparation, storage, use, inspection, violation settlement and other relevant activities.

Article 5. Effect

This Circular takes effect on 01, 2017.

Article 6. Transition provision

1. With regard to drugs and medicinal ingredients that have registration number of import permit before the date of entry into force of this Circular, holders of certificate of free sales and importers of drugs and medicinal ingredients must classify, update and provide additional information concerning classifications of drugs and medicinal ingredients in accordance with regulations herein on drug labels and package inserts according to the roadmap prescribed in Minister of Health’s Circulars on labeling of drugs and medicinal ingredients before selling such of drugs and medicinal ingredients on the market.

2. Drugs and active ingredients of which applications for sale registration in Vietnam or applications for permit to import drugs without certificate of free sale in Vietnam have been submitted to the Drug Administration of Vietnam before the date of entry into force of this Circular but are not yet processed must be classified in accordance with regulations herein.

Article 7. Implementation responsibility

1. Responsibility of pharmacy establishments and health facilities:

a) Implement regulations on management of toxic drugs and toxic medicinal ingredients on the List laid down in Article 3 herein in accordance with regulations in Minister of Health’s Circulars providing guidelines for implementation of certain Articles of the Pharmaceutical Law with regard to controlled drugs;

b) Propose revision to the List of toxic drugs and toxic medicinal ingredients in conformity with the reality to ensure the timely provision of drugs serving the prevention and treatment of diseases.

2. Responsibility of the Drug Administration of Vietnam:

a) Take charge of and cooperate with regulatory bodies in implementing this Circular;

b) Review the List of toxic drugs and toxic medicinal ingredients and submit reports thereof to the Minister of Health according to proposals and suggestions of units mentioned in Clause 1 of this Article or conclusion of the Advisory Council for issuance of certificate of free sale of drugs and medicinal ingredients.

Any difficulties arising in the course of implementation of this Circular should be promptly reported to the Drug Administration of Vietnam (affiliated to Ministry of Health) for consideration./.

For the Minister

The Deputy Minister

Truong Quoc Cuong

 

LIST

OF TOXIC DRUGS AND TOXIC MEDICINAL INGREDIENTS
(Enclosed with the Circular No. 06/2017/TT-BYT dated May 03, 2017 by Minister of Health)

No.

Toxic medicinal ingredients/ Drugs containing toxic ingredients

Administration route and dosage form

1

Abiraterone

Oral administration: various forms

2

Valproic acid

Oral administration: various forms; Intravenous administration: various forms

3

Anastrozole

Oral administration: various forms

4

Arsenic trioxide

Intravenous administration: various forms

5

Atracurium besylate

Intravenous administration: various forms

6

Atropine sulfate

Intravenous administration: various forms

7

Azacitidine

Intravenous administration: various forms

8

Bicalutamide

Oral administration: various forms

9

Bleomycin

Intravenous administration: various forms

10

Bortezomib

Intravenous administration: various forms

11

Botulinum toxin

Intravenous administration: various forms

12

Bupivacaine

Intravenous administration: various forms

13

Capecitabine

Oral administration: various forms

14

Carbamazepine

Oral administration: various forms

15

Carboplatin

Intravenous administration: various forms

16

Carmustine

Intravenous administration: various forms

17

Cetrorelix

Intravenous administration: various forms

18

Chlorambucil

Oral administration: various forms

19

Choriogonadotropin alfa

Intravenous administration: various forms

20

Cisplatin

Intravenous administration: various forms

21

Colistin

Intravenous administration: various forms

22

Conjugated Oestrogens

Oral administration: various forms

23

Cyclophosphamide

Oral administration: various forms; Intravenous administration: various forms

24

Cyclosporin

Oral administration: various forms

25

Cytarabine

Intravenous administration: various forms

26

Dacarbazine

Intravenous administration: various forms

27

Dactinomycin

Intravenous administration: various forms

28

Daunorubicin

Intravenous administration: various forms

29

Degarelix

Intravenous administration: various forms

30

Desflurane

Volatile liquid

31

Dexmedetomidine

Intravenous administration: various forms

32

Docetaxel

Intravenous administration: various forms

33

Doxorubicin

Intravenous administration: various forms

34

Entecavir

Oral administration: various forms

35

Epirubicin

Intravenous administration: various forms

36

Erlotinib

Oral administration: various forms

37

Estradiol

Intravenous administration: various forms

38

Etoposide

Oral administration: various forms; Intravenous administration: various forms

39

Everolimus

Oral administration: various forms

40

Exemestane

Oral administration: various forms

41

Fludarabine

Intravenous administration: various forms

42

Fluorouracil (5-FU)

Intravenous administration: various forms

43

Flutamide

Oral administration: various forms

44

Fulvestrant

Intravenous administration: various forms

45

Ganciclovir

Intravenous administration: various forms

46

Ganirelix

Intravenous administration: various forms

47

Gefitinib

Oral administration: various forms

48

Gemcitabine

Intravenous administration: various forms

49

Goserelin

Intravenous administration: various forms

50

Halothan

Volatile liquid

51

Hydroxyurea

Oral administration: various forms

52

Ifosfamide

Intravenous administration: various forms

53

Imatinib

Oral administration: various forms

54

Irinotecan

Intravenous administration: various forms

55

Isoflurane

Volatile liquid

56

Lenalidomide

Oral administration: various forms

57

Letrozole

Oral administration: various forms

58

Leuprorelin (also known as Leuprolide)

Intravenous administration: various forms

59

Levobupivacaine

Intravenous administration: various forms

60

Medroxy progesterone acetate

Intravenous administration: various forms

61

Menotropin

Intravenous administration: various forms

62

Mepivacaine

Intravenous administration: various forms

63

Mercaptopurine

Oral administration: various forms

64

Methotrexate

Oral administration: various forms; Intravenous administration: various forms

65

Methyltestosterone

Oral administration: various forms

66

Mitomycin C

Intravenous administration: various forms

67

Mitoxantrone

Intravenous administration: various forms

68

Mycophenolate

Oral administration: various forms

69

Neostigmine methylsulfate

Intravenous administration: various forms

70

Nilotinib

Oral administration: various forms

71

Octreotide

Intravenous administration: various forms

72

Oxaliplatin

Intravenous administration: various forms

73

Oxcarbazepine

Oral administration: various forms

74

Oxytocin

Intravenous administration: various forms

75

Paclitaxel

Intravenous administration: various forms

76

Pamidronate disodium

Oral administration: various forms; Intravenous administration: various forms

77

Pancuronium bromide

Intravenous administration: various forms

78

Pazopanib

Oral administration: various forms

79

Pemetrexed

Intravenous administration: various forms

80

Pipecuronium bromide

Intravenous administration: various forms

81

Procaine hydrocloride

Intravenous administration: various forms

82

Progesterone

Intravenous administration: various forms

83

Propofol

Intravenous administration: various forms

84

Pyridostigmine bromide

Intravenous administration: various forms

85

Ribavirin

Oral administration: various forms; Intravenous administration: various forms

86

Rocuronium bromide

Intravenous administration: various forms

87

Ropivacaine

Intravenous administration: various forms

88

Sevoflurane

Volatile liquid

89

Sirolimus

Oral administration: various forms

90

Sorafenib

Oral administration: various forms

91

Sunitinib

Oral administration: various forms

92

Suxamethonium chloride

Intravenous administration: various forms

93

Tacrolimus

Oral administration: various forms; Intravenous administration: various forms

94

Talniflumat

Oral administration: various forms

95

Tamoxifen

Oral administration: various forms

96

Temozolomide

Oral administration: various forms

97

Testosterone

Oral administration: various forms; Intravenous administration: various forms

98

Thalidomide

Oral administration: various forms

99

Thiopental

Intravenous administration: various forms

100

Thiotepa

Intravenous administration: various forms

101

Thymosin alpha I

Intravenous administration: various forms

102

Topotecan

Oral administration: various forms; Intravenous administration: various forms

103

Triptorelin

Intravenous administration: various forms

104

Tritenoin (All-Trans Retinoic Acid)

Oral administration: various forms

105

Valganciclovir

Oral administration: various forms

106

Vecuronium bromide

Intravenous administration: various forms

107

Vinblastine

Intravenous administration: various forms

108

Vincristine

Intravenous administration: various forms

109

Vinorelbine

Intravenous administration: various forms

110

Zidovudine

Oral administration: various forms

111

Ziprasidone

Oral administration: various forms

* The List includes salts of substances mentioned in the foregoing table in case they are formed and exist./.

Please log in to a subscriber account to see the full text. Don’t have an account? Register here
Please log in to a subscriber account to see the full text. Don’t have an account? Register here
Processing, please wait...
LuatVietnam.vn is the SOLE distributor of English translations of Official Gazette published by the Vietnam News Agency

ENGLISH DOCUMENTS

Others
Circular 06/2017/TT-BYT DOC (Word)

This utility is available to subscribers only. Please log in to a subscriber account to download. Don’t have an account? Register here

* Note: To view documents downloaded from LuatVietnam.vn, please install DOC, DOCX and PDF file readers
For further support, please call 19006192

SAME CATEGORY

loading